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Undernutrition during intrauterine life and early childhood is hypothesised to increase the
risk of cardiovascular disease (Developmental Origins of Health and Disease Hypothesis),
but experimental evidence from humans is limited. This hypothesis has major implications
for control of the cardiovascular disease epidemic in South Asia (home to a quarter of
world’s population), where a quarter of newborns have low birth weight. We investigated
whether, in an area with prevalent undernutrition, supplemental nutrition offered to pregnant
women and their offspring below the age of 6 years was associated with a lower risk of car-
diovascular disease in the offspring when they were young adults.
Methods and findings
The Hyderabad Nutrition Trial was a community-based nonrandomised controlled interven-
tion trial conducted in 29 villages near Hyderabad, India (1987–1990). Protein-calorie food
supplement was offered daily to pregnant and lactating women (2.09 MJ energy and 20–25
g protein) and their offspring (1.25 MJ energy and 8–10 g protein) until the age of six years
in the 15 intervention villages, but not in the 14 control villages. A total of 1,826 participants
(949 from the intervention villages and 877 from the control villages, representing 70% of
the cohort) at a mean age of 21.6 years (62% males) were examined between 2009 and
2012. The mean body mass index (BMI) of the participants was 20 kg/m2 and the mean
systolic blood pressure was 115 mm Hg. The age, sex, socioeconomic position, and urbani-
sation-adjusted effects of intervention (beta coefficients and 95% confidence intervals)
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on outcomes were as follows: carotid intima-media thickness, 0.01 mm (−0.01 to 0.03),
p = 0.36; arterial stiffness (augmentation index), −1.1% (−2.5 to 0.3), p = 0.097; systolic
blood pressure, 0.5 mm Hg (−0.6 to 1.6), p = 0.36; BMI, −0.13 kg/m2 (−0.75 to 0.09), p =
0.093; low-density lipoprotein (LDL) cholesterol, 0.06 mmol/L (−0.07 to 0.2), p = 0.37;
and fasting insulin (log), −0.06 mU/L (−0.19 to 0.07), p = 0.43. The limitations of this study
include nonrandomised allocation of intervention and lack of data on compliance, and poten-
tial for selection bias due to incomplete follow-up.
Conclusions
Our results showed that in an area with prevalent undernutrition, protein-calorie food supple-
ments offered to pregnant women and their offspring below the age of 6 years were not
associated with lower levels of cardiovascular risk factors among offspring when they were
young adults. Our findings, coupled with evidence from other intervention studies to date,
suggest that policy makers should attach limited value to cardiovascular health benefits of
maternal and child protein-calorie food supplementation programmes.
Author summary
Why was the study done?
• Some researchers say that poor nutrition of the mother in pregnancy can increase the
risk of heart disease in her children.
• If true, this theory could help to explain the high risk of heart disease among South
Asians, in whom low birth weight is very common.
• Evidence for this theory from intervention studies (in which some people are exposed to
treatment and others are not) is limited.
What did the researchers do and find?
• The Hyderabad Nutrition Trial was conducted previously (1987–1990) in an area with
high levels of undernutrition in Telangana state, India; extra food (500 calories and 20 g
protein) was offered daily to all pregnant women and their children below the age of 6
years in 15 villages out of a total of 29 villages.
• The researchers examined 1,826 children born during this trial when their average age
was 22 years.
• They found no difference in risk of heart disease between offspring born to women who
were offered extra food in pregnancy and childhood and those who were not.
What do these findings mean?
• Our results showed that extra food offered to undernourished pregnant women may
not lower their offspring’s risk of heart disease in young adulthood.
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• Our findings suggest that, until further evidence is available, policy makers should
attach limited value to heart health benefits of food supplementation programmes for
pregnant women and young children.
Introduction
Cardiovascular disease is the leading cause of death and disability worldwide. The striking
rise in the prevalence of cardiovascular disease in many low- and middle-income countries
(LMICs), notably South Asia, is unexplained by population ageing and lifestyle changes associ-
ated with economic transition [1,2]. Social disadvantage in the early years of life appears to
account for some of the increase in risk, but the biological mechanisms for this association are
unknown [3]. A series of reports linking low birth weight to cardiovascular disease, as well as
supportive animal models, have led to the hypothesis that undernutrition during intrauterine
life and early childhood (critical or sensitive period) may have long-lasting effects on the future
risk of cardiovascular disease through persistence of metabolic and physiological adaptations
(Developmental Origins of Health and Disease Hypothesis) [4–7]. However, most of these
studies were conducted in high-income countries, where maternal smoking during pregnancy
is a more common cause of low birth weight than undernutrition, leading other researchers to
suggest that the observed associations may be confounded by behavioural risks associated with
persistent social disadvantage [8,9].
Few studies have been able to test this hypothesis in a trial setting, and the findings have
been inconsistent [10–12]. We assessed cardiovascular disease risk factors among a cohort of
young adults who were born during a trial of protein-calorie supplemental nutrition offered to
pregnant women and young children in an area with prevalent undernutrition. We hypothe-
sised that supplemental nutrition during pregnancy and early childhood would be associated
with lower levels of cardiovascular disease risk factors in young adulthood.
Methods
The study is reported in accordance with the CONSORT guideline (S1 CONSORT checklist).
The Hyderabad Nutrition Trial (1987–1990) was a community-based nonrandomised con-
trolled intervention trial conducted in 29 villages of Ranga Reddy district in Telangana state,
India [12,13]. It evaluated India’s Integrated Child Development Services (ICDS) scheme,
which is a long-standing scheme aimed at improving child growth and development through
integrated provision of food supplementation, anaemia control, immunisation, education, and
basic healthcare to pregnant and lactating women and children up to 6 years [13]. Using the
opportunity afforded by the gradual rollout of this nationwide scheme during the 1980s and
1990s, the National Institute of Nutrition of India conducted the trial to assess the effect of
food supplementation in pregnancy on the offspring’s birth weight. A cluster of villages was
chosen from two adjacent administrative areas (called ‘blocks’): one with the ICDS scheme in
place (intervention arm) and the other awaiting implementation at that time (control arm)
(Fig 1). As the 100 or so villages in each of the two blocks were spread over an unfeasibly large
area for data collection, contiguous villages surrounding the geographic centre of each block
were selected to make up the planned sample size of 30,000 total population in each block.
This resulted in 15 intervention and 14 control villages geographically separated by uninvolved
villages. The food supplement (‘upma’, a local food prepared from corn-soya blend and soya
bean oil) was offered daily to women throughout pregnancy and lactation (2.51 MJ of energy
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and 20–25 g of protein daily) and children below the age of 6 years (1.25 MJ and 8–10 g protein
daily). A total of 2,964 birth weights were recorded within 48 hours of delivery with an infant
beam balance with an accuracy of 20 g (John Chatillon & Sons, NY). The mean birth weight of
children born in the intervention area was higher than control (2,655 g versus 2,594 g), with a
mean difference of 61 g (95% confidence interval 18 to 104; p = 0.007) [12,14]. The trial was
not registered, as it was not standard practice to register community trials at that time. The
trial families were recontacted in 2003–2005; offspring born in the trial (N = 2,601) and their
parents and siblings constitute the intergenerational Andhra Pradesh Children and Parents
study (APCAPs) [15].
The offspring born during the trial have been followed up three times: first follow-up in
2003–2005 (mean age 16 years; N = 1,165), second follow-up in 2009–2010 (mean age of 20
years; N = 1,446), and third follow-up in 2010–2012 (mean age of 22 years; N = 1,360) (Fig 2).
Fewer participants were invited for examination at the first follow-up (N = 1,492, 78%
response) due to resource constraints (it was a PhD project funded by a small travel award);
priority was given to those on whom additional data on compliance and growth were thought
to be available at that time. At the time of the first follow-up at age 16 years, children born in
the intervention villages were found to be taller and had lower levels of arterial stiffness and
insulin resistance, suggesting lower risk of cardiovascular disease [12]. In this report, we pres-
ent the findings from the second and third follow-ups of trial offspring. The third follow-up
was conducted primarily to extend the study to parents and siblings of the trial offspring;
however, the trial offspring were also offered the opportunity to take part again, resulting
in the close timing of the two surveys. Given the close timing and a substantial number of
Fig 1. Map of APCAPs villages. Village urbanisation measured by nighttime light intensity assessed by remote sensing. Background maps were rendered
by the authors using R, based on geodata made available by Geofabrik.de and OpenStreetMap.org, under the Open Database License (https://
opendatacommons.org/licenses/odbl/1.0/). APCAPs, Andhra Pradesh Children and Parents study.
https://doi.org/10.1371/journal.pmed.1003183.g001
PLOS MEDICINE Pregnancy supplementation and offspring cardiovascular risk
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003183 July 21, 2020 4 / 17
nonoverlapping participants, we combined data from the two follow-ups to maximise study
power and reduce selection bias. Where individual participant data were available from both
surveys, we used data from the later survey wave because our primary interest was in cardio-
vascular risk in adulthood. This resulted in 1,826 participants at a mean age of 21.6 years
(62% males). Since the first follow-up, the peri-urban study villages have experienced rapid
unplanned urbanisation, which we quantified using data from remote sensing and took into
account in our analyses (see details later) [16]. Ethical approvals for second and third follow-
ups of the cohort were obtained from the Public Health Foundation of India, New Delhi,
Fig 2. Flowchart of APCAPs study participants at the first, second, and third follow-ups, 2003–2012. APCAPs, Andhra Pradesh Children and Parents
study.
https://doi.org/10.1371/journal.pmed.1003183.g002
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India; National Institute of Nutrition, Hyderabad, India; University of Bristol, Bristol, United
Kingdom; and the London School of Hygiene & Tropical Medicine (LSHTM), London,
UK. Verbal permissions were taken from heads and governing committees of the villages.
Written informed consent (or witnessed thumbprint if illiterate) for inclusion in the study was
obtained from each participant prior to enrolment.
Measurements
The study participants were interviewed and examined by trained observers using standard-
ised methods, which have been described in detail previously (full protocol in S1 Text) [15].
No change was made to the study protocol after the start of the study. Sociodemographic
and lifestyle (i.e., tobacco and alcohol use) data were collected using standard questions from
India’s Third National Family Health Survey [16]. Socioeconomic position was assessed using
a subset of 14 questions (out of 29) of the Standard of Living Index (SLI) and applying the pre-
scribed weights; a higher score indicates a higher socioeconomic position. A semiquantitative
food frequency questionnaire coupled with customised nutrient databases was used to estimate
average daily salt and fat consumption and energy intake; its validation against multiple
weighed 24-hour recalls in this setting has been published [17]. Physical activity was assessed
using a validated questionnaire (activities over the past week), which was used to derive meta-
bolic equivalent tasks (METs; expressed in hours/day) and time spent sedentary (minutes/
day); its validation against triaxial accelerometers in this setting has been published [18].
Anthropometric assessments were carried out using standard protocols [15]. Weight was mea-
sured with a digital weighing scale (SECA, www.seca.com) and standing height with a plastic
stadiometer (Leicester measure; Chasmors, London, UK). Waist circumference was measured
using a non-stretch metallic tape at the narrowest point of the abdomen between the ribs and
the iliac crest. Anthropometric measurements were taken twice and averaged for analyses;
where the difference between readings was more than the acceptable level (5 mm for height,
0.5 kg for weight, and 1 cm for waist circumference), a third reading was taken.
Vascular assessments were carried out using recommended guidelines, as described previ-
ously [19]. Blood pressure was measured on the right arm in the supine position using a vali-
dated oscillometric device (Model M5-I; Omron, Matsusaka, Japan) with appropriate cuff
size. Arterial stiffness (augmentation index and aortic pulse wave velocity) and central systolic
blood pressure were assessed using a Vicorder device (Skidmore Medical, Bristol, UK); higher
values for arterial stiffness measures indicate stiffer arteries and increased vascular age. Blood
pressure cuffs were placed around the neck (at the level of carotid artery) and upper thigh and
inflated to 60 mm Hg before recording the waveforms. Three consecutive measurements of
blood pressure and arterial stiffness were taken after a rest of five minutes (one minute of rest
between readings) and then averaged for analyses. Carotid intima media thickness was mea-
sured on the near wall of the distal common carotid artery (right-hand side) using a B-mode
ultrasound (Ethiroli Tiny 16a; Surabhi Biomedical Instrumentation, Chennai, India). Images
were normalised before analyses by Carotid Plaque Texture Analysis software (LifeQ, Engomi,
Cyprus). Two measurements of carotid intima media thickness were taken by separate opera-
tors and averaged for analysis.
Venous blood samples were collected after an overnight fast. Glucose was assayed on the
same day using the oxidase-peroxidase enzymatic (GOD-PAP) method (reagents supplied by
Randox Laboratory, Crumlin city, UK). An enzymatic colorimetric method was used to assay
total cholesterol, triglycerides, and serum high-density lipoprotein cholesterol (HDL-C). Lipids
and insulin assays were carried out using reagents supplied by Roche Diagnostics, Basel, Switzer-
land. Serum insulin was assayed on an e-411 autoanalyser using an electrochemiluminescence
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immunoassay. The quality of biochemical assays was assured through internal controls and
external assurance arrangements with Randox International Quality Assessment Scheme (lipids)
and UK National External Quality Control Assessment Service (insulin). Intra- and inter-assay
coefficients of variation were�3% and�5%, respectively, for all assays.
Quality of clinical measurements was ensured through rigorous protocols, regular standar-
disation of equipment, and teams to detect any drifts over time [15]. Reproducibility of mea-
surements was evaluated by repeat measurements on a 5% random subsample; the intraclass
correlation coefficients were >0.98 for anthropometric measurements, >0.85 for vascular
measurements, and >0.94 for biochemical assays.
Village urbanisation was quantified using nighttime light intensity (NTLI), a data product
derived from satellite sensors that capture visible near-infrared emissions from the earth’s sur-
face, which has been used to measure urbanisation and predict cardio-metabolic risk in several
settings, including APCAPs cohort participants [19,20]. Geocoded village boundaries were
applied to 2012 data from the Defense Meteorological Satellite Program (Operational Linescan
System) accurate to a 1-km resolution, such that NTLI values represent emissions from the vil-
lage areas only.
Statistical analyses
We compared values of cardiovascular risk factors in intervention and control villages using a
linear regression model and assessed the effect of the intervention using beta coefficients. We
fitted a random intercept at both village and household levels, to allow for clustering of out-
comes. Adiposity was estimated by body mass index (BMI); pulse pressure as difference
between systolic and diastolic blood pressure; low-density lipoprotein (LDL) cholesterol using
the Friedewald-Fredrickson formula; and insulin resistance by homeostatic model assessment-
insulin resistance (HOMA-IR). We log-transformed the following variables prior to analyses
to achieve a more Gaussian distribution: triglycerides, insulin, and HOMA-IR. Values of insu-
lin were standardised across the two waves in order to allow for differences in assay techniques.
Analyses were carried out using the ‘intention-to-treat’ principle, comparing risk factors of
children born in the intervention and control areas. In view of the nonrandomised trial design
and varying urbanisation of the study villages over the long-term follow-up, we fitted three
predefined models to incrementally adjust for potential differences in sociodemographic
and lifestyle factors that could influence the levels of cardiovascular risk factors: model 1 was
adjusted for age and sex; model 2 was additionally adjusted for socioeconomic position and
village urbanisation; and model 3 was further adjusted for lifestyle factors, including tobacco
and alcohol use, fat and salt consumption, and physical activity level and sedentariness. We
used formal tests of interactions to examine whether the effects of membership of treatment
arm on outcomes were modified by age (split by median age of 22 years), sex, village urbanisa-
tion (thirds) and current obesity (split by median of 20 kg/m2). To assess the impact of poten-
tial difference in samples between first and second or third follow-ups, we restricted the
analyses to those who also presented at the first follow-up (sensitivity analyses).
Results
A total of 1,826 (70% of cohort) participants were examined at least once between 2009 and
2012, of which 881 were also examined during the first follow-up in 2003–2005. In compari-
sons of cardiovascular risk factor data collected in the first follow-up, those who took part in
the second or third follow-ups were broadly similar to those who took part in the first follow-
up alone (Table 1).
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Table 1. Participant characteristics in 2003–2005 split by presentation in 2009–2012.
Characteristics Absent in 2009–2012 (n = 284) Present in 2009–2012 (n = 881) p-Value
ALL PARTICIPANTS
From intervention village 154 (58.6%) 475 (57.9%) 0.84
Age (years) 15 (1) 15 (1) 0.94
Male sex 60 (22.8%) 529 (64.4%) <0.001
Village urbanisation score 0.96
Least urbanised third 71 (27.1%) 233 (28.4%)
Middle third 91 (34.7%) 277 (33.8%)
Most urbanised third 100 (38.2%) 310 (37.8%)
SLI score <0.001
Bottom third 57 (21.5%) 300 (36.6%)
Middle third 90 (34.0%) 263 (31.3%)
Top third 118 (44.5%) 257 (31.3%)
Occupation <0.001
Unemployed 25 (9.2%) 60 (7.2%)
Student 203 (74.4%) 703 (83.9%)
Employed 45 (16.5%) 75 (8.9%)
Height (cm) 149.1 (14.1) 150.1 (7.6) 0.18
BMI (kg/m2) 20.7 (4.4) 20.7 (4.2) 0.85
Systolic blood pressure (mm Hg) 108.3 (9.2) 109.2 (10.5) 0.20
Total cholesterol (mmol/L) 3.6 (0.7) 3.4 (0.7) <0.001
Insulin (mU/L) 19.0 (12.1 to 26.4) 16.8 (10.9 to 24.9) 0.01
Augmentation index (%) 5.0 (−2.5 to 10.5) 5.0 (−3.5 to 11.0) 0.67
CONTROL PARTICIPANTS
From intervention village 0 (0.0%) 0 (0.0%)
Age (years) 15 (1) 15 (1) 0.28
Male sex 28 (25.7%) 225 (65.0%) <0.001
Village urbanisation score 0.001
Least urbanised third 39 (35.8%) 141 (40.8%)
Middle third 45 (41.3%) 82 (23.7%)
Most urbanised third 25 (22.9%) 123 (35.5%)
SLI score <0.001
Bottom third 19 (18.4%) 127 (39.9%)
Middle third 39 (37.9%) 102 (32.1%)
Top third 45 (43.7%) 89 (28.0%)
Occupation 0.06
Unemployed 10 (9.7%) 34 (10.6%)
Student 75 (72.8%) 258 (80.4%)
Employed 18 (17.5%) 29 (9.0%)
Height (cm) 149.7 (6.2) 150.2 (6.0) 0.56
Body mass index (kg/m2) 20.8 (5.0) 20.8 (4.1) 1.00
Systolic blood pressure (mm Hg) 109.6 (8.7) 109.3 (10.2) 0.80
Total cholesterol (mmol/L) 3.5 (0.6) 3.4 (0.7) 0.036
Insulin (mU/L) 21.3 (14.1 to 30.8) 18.1 (12.5 to 26.9) 0.038
Augmentation index (%) 6.3 (2.5 to 10.3) 6.5 (−1.5 to 12.0) 0.73
INTERVENTION PARTICIPANTS
From intervention village 154 (100.0%) 475 (100.0%)
Age (years) 15 (1) 15 (1) 0.41
(Continued)
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The mean age of the participants was 21.6 years (62% males) (Table 2). Just over half of the
participants were employed and about a quarter were in full-time education. About 10% con-
sumed tobacco and mean BMI was 20 (SD 3.2) kg/m2. The village urbanisation score was
clearly different between trial arms: about 20% of the intervention arm participants lived in the
least urbanised third of villages, as opposed to 44% in the control arm (3 villages in interven-
tion arm and 7 villages in control arm belonged to the least urbanised thirds category). Missing
data, notably for arterial stiffness and carotid intima media thickness measurements (relatively
more due to greater time commitment required from the participants), were evenly distributed
across the trial arms. There were no differences in the levels of cardiovascular risk factors
between trial arms (Table 3). There was no strong evidence for effect modification by age, sex,
village urbanisation and current obesity (see S1, S2, S3 and S4 Tables). In sensitivity analyses
restricted to participants who were also examined in the first follow-up, results were broadly
similar; although borderline effects of intervention on some outcomes (height, augmentation
index, and HOMA score) were noted in models adjusted for socioeconomic position and
urbanisation, their confidence intervals overlapped with those for effect estimates for the full
cohort (Table 4).
Discussion
In this long-term follow-up of a community-based nonrandomised controlled intervention
trial conducted in an area with prevalent undernutrition, provision of supplemental nutrition
to pregnant and lactating women (2.09 MJ energy and 20–25 g protein daily) and their
Table 1. (Continued)
Characteristics Absent in 2009–2012 (n = 284) Present in 2009–2012 (n = 881) p-Value
Male sex 32 (20.8%) 304 (64.0%) <0.001
Level of urbanisation (thirds) 0.042
Least urbanised 32 (20.9%) 92 (19.4%)
Middle third 46 (30.1%) 195 (41.1%)
Most urbanised 75 (49.0%) 187 (39.5%)
SLI score 0.002
Bottom third 30 (21.0%) 156 (32.5%)
Middle third 45 (31.5%) 137 (30.9%)
Top third 68 (47.6%) 150 (33.9%)
Occupation 0.036
Unemployed 12 (8.0%) 22 (4.8%)
Student 116 (77.3%) 394 (86.2%)
Employed 22 (14.7%) 41 (9.0%)
Height (cm) 148.7 (17.2) 150.0 (8.6) 0.24
Body mass index (kg/m2) 20.7 (4.1) 20.6 (4.3) 0.79
Systolic blood pressure (mm Hg) 107.4 (9.4) 109.2 (10.7) 0.067
Total cholesterol (mmol/L) 3.7 (0.7) 3.4 (0.7) <0.001
Insulin (mU/L) 16.7 (11.3 to 25.2) 15.6 (10.2 to 22.3) 0.090
Augmentation index (%) 2.5 (−5.3 to 11.3) 3.0 (−5.0 to 10.5) 0.82
Data shown are number (%), mean (standard deviation), or median (interquartile range).
Data shown are only for those who took part in the 2003–2005 follow-up.
Abbreviations: BMI, body mass index; SLI, Standard of Living Index
https://doi.org/10.1371/journal.pmed.1003183.t001
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offspring until the age of 6 years (1.25 MJ energy and 8–10 g protein daily) was not associated
with lower levels of cardiovascular disease risk factors (such as blood pressure, fasting blood
lipids and insulin, arterial stiffness, and carotid intima media thickness) among the offspring
when they became young adults (mean age 22 years).
Table 2. Distribution of cardiovascular risk factors of APCAPs participants in 2009–2012.
Risk factors Missing data� (%) Intervention (n = 949) Control (n = 877) p-Value
Age (years) 0.0% 21.7 (1.8) 21.6 (1.9) 0.79
Male 0.0% 580 (61.1%) 530 (60.4%) 0.78
Village urbanisation score 0.4% 0.32
Least urbanised third 185 (19.7%) 381 (43.4%)
Middle third 400 (42.5%) 202 (23.0%)
Most urbanised third 356 (37.8%) 294 (33.5%)
Occupation 0.0% 0.26
Unemployed 209 (22.0%) 188 (21.4%)
Student 259 (27.3%) 202 (23.0%)
Employed 481 (50.7%) 487 (55.5%)
SLI score 0.5% 0.65
Bottom third 208 (22.0%) 215 (24.6%)
Middle third 336 (35.6%) 300 (34.4%)
Top third 400 (42.4%) 358 (41.0%)
Tobacco use (current/former) 0.1% 117 (12.3%) 90 (10.3%) 0.18
Alcohol use (daily) 0.1% 25 (2.6%) 22 (2.5%) 0.82
Time spent sedentary (hours/day) 1.4% 5.5 (3.6 to 7.9) 5.6 (3.5 to 8.5) 0.95
Physical activity (MET-hours/day) 1.5% 36.4 (34.1 to 39.0) 36.3 (34.0 to 39.6) 0.44
Salt consumption (g/day) 0.2% 2.0 (1.7 to 2.3) 2.0 (1.7 to 2.2) 0.34
Fat consumption (% energy intake) 0.2% 18.8 (5.4) 18.6 (5.5) 0.51
Height (mm) 0.0% 1616.6 (90.3) 1614.8 (90.4) 0.73
BMI (kg/m2) 0.0% 20.1 (3.3) 20.1 (3.1) 0.44
Waist circumference (mm) 0.2% 691.7 (86.6) 693.5 (81.6) 0.43
Systolic blood pressure (mm Hg) 0.1% 115.2 (10.4) 114.2 (10.0) 0.23
Diastolic blood pressure (mm Hg) 0.1% 73.5 (9.7) 72.2 (9.5) 0.088
Pulse pressure (mm Hg) 0.1% 41.6 (6.2) 42.0 (6.3) 0.45
Augmentation index (%) 26.1% 12.9 (7.1) 14.5 (7.5) 0.086
Central systolic BP (mm Hg) 22.0% 106.4 (9.4) 106.9 (9.6) 0.48
Pulse wave velocity (m/sec) 13.7% 6.0 (0.7) 5.9 (0.6) 0.23
Carotid IMT (mm) 33.1% 0.55 (0.11) 0.56 (0.12) 0.75
Total cholesterol (mmol/L) 1.0% 4.1 (1.0) 4.0 (0.8) 0.28
LDL cholesterol (mmol/L) 1.4% 2.4 (0.8) 2.3 (0.7) 0.12
HDL cholesterol (mmol/L) 1.0% 1.1 (0.3) 1.1 (0.3) 0.56
Triglycerides (mmol/L) 1.0% 1.1 (0.8 to 1.4) 1.0 (0.8 to 1.4) 0.41
Fasting glucose (mmol/L) 1.0% 4.9 (4.5 to 5.2) 4.8 (4.5 to 5.1) 0.94
Insulin (mU/L) 1.4% 6.2 (4.0 to 9.5) 5.8 (3.6 to 8.9) 0.49
HOMA-IR 1.4% 1.2 (0.7 to 1.9) 1.1 (0.7 to 1.7) 0.64
Data shown are number (%), mean (standard deviation), or median (interquartile range).
�No significant differences (at p< 0.05) in percent missing data between trial arms.
Abbreviations: APCAPs, Andhra Pradesh Children and Parents study; BMI, body mass index; BP, blood pressure; HDL, is high-density lipoprotein; HOMA-IR,
homeostatic model assessment-insulin resistance; IMT, is intima-media thickness; LDL, low-density lipoprotein; MET, metabolic equivalent task; SLI, Standard of
Living Index
https://doi.org/10.1371/journal.pmed.1003183.t002
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Strengths and limitations
The trial was conducted in an area with chronic undernutrition and homogeneous socioeco-
nomic conditions, and women did not consume tobacco, limiting the potential for confound-
ing by maternal and social factors. The subsequent unplanned urbanisation of the study
villages, typical of peri-urban sprawls across many LMICs, allowed investigations into the
effects of subsequent changes in environment, and make findings generalisable to transition-
ing areas of other LMICs. The loss to follow-up was relatively low in comparison to similar
studies with long-term follow-up, limiting the potential for selection bias [15]. While out-
migration for education and employment in young adulthood tends to be high, we may have
benefitted from the proximity of the study villages to the urban centre, allowing many people
to stay at home and commute to their place of work/study on a daily basis (>95% still reside in
the village of their birth).
There are several limitations to this study that must be acknowledged. First, the villages in
the trial were not randomised, raising the possibility of bias from other differences between
trial areas. Although the control district was awaiting implementation of the intervention at
the time of the trial (and did receive it a few years later in 1992–1993), the intervention district
may have may have received the intervention earlier because of some other reason (e.g., politi-
cal), which could be associated with other differences between the trial areas that could influ-
ence health outcomes. Second, we lacked data on compliance with the intervention. Anecdotal
reports from investigators involved in the trial suggest that women in the trial were severely
undernourished and collection of supplements was high, but the intake was not directly
Table 3. Multivariable association between supplemental nutrition and cardiovascular risk factors of APCAPs participants in 2009–2012.
Outcome N with data Model 1 Model 2 Model 3
β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value
Height (mm) 1,783 1 (−5 to 8) 0.70 2 (−5 to 8) 0.63 1 (−5 to 7) 0.70
BMI (kg/m2) 1,783 −0.18 (−0.65 to 0.29) 0.45 −0.33 (−0.75 to 0.09) 0.12 −0.35 (−0.76 to 0.06) 0.093
Waist circumference (mm) 1,779 −5 (−15 to 6) 0.40 −8 (−17 to 1) 0.100 −9 (−18 to 1) 0.065
Systolic BP (mm Hg) 1,782 1.0 (−0.3 to 2.2) 0.13 0.5 (−0.6 to 1.6) 0.34 0.5 (−0.6 to 1.6) 0.36
Diastolic BP (mm Hg) 1,782 1.2 (−0.1 to 2.5) 0.075 0.8 (−0.2 to 1.7) 0.10 0.7 (−0.2 to 1.6) 0.12
Central systolic BP (mm Hg) 1,395 −0.1 (−1.2 to 1.0) 0.88 −0.2 (−1.2 to 0.9) 0.73 −0.2 (−1.2 to 0.8) 0.72
Pulse pressure (mm Hg) 1,782 −0.28 (−0.83 to 0.26) 0.31 −0.15 (−0.70 to 0.39) 0.58 −0.13 (−0.68 to 0.42) 0.65
Augmentation index (%) 1,322 −1.1 (−2.6 to 0.3) 0.12 −1.1 (−2.5 to 0.3) 0.12 −1.2 (−2.6 to 0.2) 0.097
Pulse wave velocity (m/s) 1,542 0.05 (−0.03 to 0.13) 0.25 0.03 (−0.04 to 0.10) 0.39 0.02 (−0.04 to 0.09) 0.48
Carotid IMT (mm) 1,194 0.01 (−0.02 to 0.03) 0.62 0.01 (−0.01 to 0.03) 0.32 0.01 (−0.01 to 0.03) 0.36
Total cholesterol (mmol/L) 1,764 0.12 (−0.08 to 0.32) 0.23 0.07 (−0.13 to 0.27) 0.48 0.06 (−0.13 to 0.26) 0.52
LDL cholesterol (mmol/L) 1,756 0.13 (−0.02 to 0.28) 0.089 0.06 (−0.07 to 0.20) 0.36 0.06 (−0.07 to 0.19) 0.37
HDL cholesterol (mmol/L) 1,764 −0.02 (−0.09 to 0.05) 0.66 0.01 (−0.06 to 0.07) 0.88 0.00 (−0.06 to 0.07) 0.89
Log triglycerides (mmol/L) 1,763 0.03 (−0.03 to 0.08) 0.34 0.02 (−0.04 to 0.07) 0.53 0.02 (−0.04 to 0.07) 0.58
Fasting glucose (mmol/L) 1,763 −0.02 (−0.11 to 0.08) 0.08 −0.02 (−0.10 to 0.06) 0.57 −0.03 (−0.11 to 0.05) 0.49
Log insulin (mU/L) 1,756 0.04 (−0.12 to 0.21) 0.73 −0.05 (−0.18 to 0.08) 0.48 −0.05 (−0.18 to 0.08) 0.43
Model 1 is age and sex adjusted.
Model 2 is further adjusted for socioeconomic position and village urbanisation.
Model 3 is adjusted for variables in model 2 plus behavioural risk factors (tobacco and alcohol use; salt and fat consumption; and physical activity level and
sedentariness).
Abbreviations: APCAPs, Andhra Pradesh Children and Parents study; BMI, body mass index; BP, blood pressure, HDL, high-density lipoprotein; HOMA-IR,
homeostatic model assessment-insulin resistance; IMT, intima-media thickness; LDL, low-density lipoprotein; β (95% CI), beta coefficient and 95% confidence interval
https://doi.org/10.1371/journal.pmed.1003183.t003
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observed. External reports of the ICDS programme suggest that families often share the sup-
plement with other children at home, which could have attenuated the effect of intervention.
The lack of data on compliance raises the possibility that the intervention dose may not have
been adequate to test the hypothesis robustly. There are no suitable data to guide adequacy of
dose of nutritional supplementation, which would be conditional on usual diet from other
sources. The ICDS scheme provides approximately 25% of daily energy and protein require-
ment for the women, and approximately 25% of energy and approximately 50% of protein
requirement for the children. The 61 g (95% CI 18–104) difference in birth weight between the
trial arms (intervention 2,655 g, control 2,594 g) compares favourably to the mean birth weight
difference (41 g; 95% CI 4.7–77.3) reported in a systematic review of trials in which protein-
calorie supplementation in pregnancy was directly observed, suggesting that most of the sup-
plement was consumed by the intended beneficiary [12,13,21].
Third, about a third of the cohort could not be followed up. Simple comparison of data
collected at the time of first follow-up showed no material difference between those who took
part or did not take part in the second or third follow-ups (Table 1); nevertheless, potential
bias in results due to systematic differences in characteristics of those lost to follow-up cannot
be ruled out. Fourth, participants and observers who collected field data were not ‘blind’ to the
intervention allocation, which could introduce bias; however, data collection on several out-
comes was either automated or processed by those who were blind to the allocation of inter-
vention (e.g., biochemical assays), reducing the likelihood of such bias. Finally, given the age of
Table 4. Multivariable association between supplemental nutrition and cardiovascular risk factors in 2009–2012 in APCAPs participants who also presented in
2003–2005.
Outcome N with data Model 1 Model 2 Model 3
β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value
Height (mm) 863 6 (−2 to 14) 0.12 7 (−1 to 15) 0.095 7 (−1 to 15) 0.089
BMI (kg/m2) 863 −0.43 (−0.90 to 0.05) 0.080 −0.50 (−0.94 to −0.06) 0.027 −0.51 (−0.98 to −0.05) 0.031
Waist circumference (mm) 862 −9 (−21 to 3) 0.13 −11 (−21 to −0) 0.044 −11 (−22 to −0) 0.043
Systolic BP (mm Hg) 862 0.4 (−1.1 to 1.8) 0.63 0.1 (−1.3 to 1.4) 0.94 0.0 (−1.3 to 1.4) 0.95
Diastolic BP (mm Hg) 862 0.8 (−0.4 to 2.0) 0.20 0.4 (−0.9 to 1.6) 0.56 0.3 (−1.0 to 1.5) 0.69
Central systolic BP (mm Hg) 691 −0.8 (−2.1 to 0.6) 0.26 −0.7 (−2.1 to 0.7) 0.30 −0.7 (−2.1 to 0.7) 0.32
Pulse pressure (mm Hg) 862 −0.4 (−1.1 to 0.4) 0.32 −0.3 (−1.0 to 0.5) 0.49 −0.2 (−0.9 to 0.6) 0.66
Augmentation index (%) 663 −2.2 (−3.7 to −0.7) 0.005 −2.3 (−3.8 to −0.8) 0.002 −2.3 (−3.7 to −0.8) 0.002
Pulse wave velocity (m/s) 767 0.03 (−0.08 to 0.14) 0.61 0.02 (−0.08 to 0.12) 0.74 0.01 (−0.09 to 0.10) 0.90
Carotid IMT (mm) 585 −0.00 (−0.03 to 0.02) 0.70 −0.00 (−0.02 to 0.02) 0.99 0.00 (−0.02 to 0.02) 0.96
Total cholesterol (mmol/L) 855 0.08 (−0.14 to 0.30) 0.49 0.02 (−0.20 to 0.23) 0.88 0.00 (−0.21 to 0.22) 0.96
LDL cholesterol (mmol/L) 852 0.07 (−0.11 to 0.25) 0.42 −0.02 (−0.17 to 0.13) 0.80 −0.02 (−0.17 to 0.12) 0.75
HDL cholesterol (mmol/L) 855 −0.00 (−0.08 to 0.08) 0.97 0.02 (−0.06 to 0.10) 0.63 0.02 (−0.06 to 0.10) 0.63
Log triglycerides (mmol/L) 854 0.03 (−0.04 to 0.10) 0.43 0.02 (−0.05 to 0.09) 0.54 0.02 (−0.05 to 0.09) 0.64
Fasting glucose (mmol/L) 855 −0.03 (−0.13 to 0.07) 0.59 −0.01 (−0.11 to 0.09) 0.81 −0.02 (−0.12 to 0.08) 0.68
Log insulin (mU/L) 854 −0.05 (−0.21 to 0.11) 0.54 −0.12 (−0.26 to 0.01) 0.073 −0.14 (−0.27 to −0.00) 0.045
Log HOMA-IR 854 −0.06 (−0.22 to 0.10) 0.46 −0.13 (−0.26 to 0.00) 0.056 −0.14 (−0.27 to −0.01) 0.030
Model 1 is age and sex adjusted.
Model 2 is further adjusted for socioeconomic position and village urbanisation.
Model 3 is adjusted for variables in model 2 plus behavioural risk factors (tobacco and alcohol use; salt and fat consumption; and physical activity level and
sedentariness).
Abbreviations: APCAPs, Andhra Pradesh Children and Parents study; BMI, body mass index; BP, blood pressure, IMT, intima-media thickness; LDL, low-density
lipoprotein; HDL is High-density Lipoprotein; HOMA-IR, Homeostatic Model Assessment-Insulin Resistance; β (95% CI), beta coefficient and 95% confidence interval
https://doi.org/10.1371/journal.pmed.1003183.t004
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the participants and the rural study setting, the levels of cardiovascular disease risk factors
were relatively low, reducing our ability to detect differences. As rates of cardiovascular disease
tend to increase more rapidly with age in India than in many other countries, further follow-
up of participants in mid-adulthood will generate more robust data on incident cardiovascular
disease [22].
Comparison with previous research
There are few trials of protein-calorie nutritional supplementation offered to pregnant women
and young children with follow-up for cardiovascular risk in adulthood. A cluster randomised
trial in The Gambia (28 villages; N = 1,317) provided protein-calorie supplements (4.25 MJ of
energy and 22 g protein daily) to pregnant (intervention, from 20-week gestation until deliv-
ery) or lactating (control, from 20-week gestation until delivery) women, and found no differ-
ence in cardiovascular risk factors (blood pressure, body composition, blood cholesterol, and
fasting glucose) among offspring when they were aged 11–17 years [10]. Another cluster ran-
domised trial from Guatemala (4 villages; N = 429) offered 3.8 MJ of energy and 64 g protein
(intervention) or 1.4 MJ of energy (control) supplements twice daily to pregnant and lactating
women and children until the age of 7 years and found no difference in cardiovascular risk fac-
tors among offspring when they were aged 24 years; however, in subgroup analyses, interven-
tion between the ages of 3 and 6 years was associated with lower fasting glucose and systolic
blood pressure, while intervention between birth and 3 years was associated with lower triglyc-
eride and higher high-density lipoprotein cholesterol levels [11]. A trial from rural Bangladesh
offered protein-calorie supplementation to pregnant women in early or late pregnancy; at a
follow-up conducted at age 4.5 years, early supplementation was associated with lower dia-
stolic blood pressure, but findings in adulthood have not been reported [23].
At the time of the first follow-up of the APCAPs cohort, nutritional supplementation was
associated with beneficial effects on several cardiovascular risk factors (i.e., height, arterial
stiffness, and insulin resistance) (Fig 3) [12]. There are several potential explanations for
the difference in findings between the first follow-up (mean age 16 years) and the second or
third follow-up (mean age 22 years) reported here. Assuming a true null as the most likely
explanation, the positive findings in the first follow-up could have been due to chance (par-
ticularly since multiple statistical tests were conducted) or selection bias (participants from
the intervention villages with favourable outcomes selectively presenting for examination at
the first follow-up). There was weak evidence in favour of the latter hypothesis in the present
analyses when the sample was restricted to offspring who were also part of the first follow-
up; borderline associations were seen for relevant outcomes, although the overlapping
confidence intervals were consistent with no difference between follow-ups (Tables 3 and 4).
Alternatively, a true effect of the intervention in adolescence may been attenuated over the
long-term follow-up due to nutrition or economic transition [6,7], which would support the
view that the risk of cardiovascular disease accumulates across the life course [17]. Between
1991 and 2011, the population of study villages increased by 31% (census data), and NTLI
and built-up land use (both from remote sensing data) increased by 156% and 196%, respec-
tively, confirming urbanisation of the study villages, which was also found to be associated
strongly with cardiovascular risk factors in APCAPs participants [24]. There was some sup-
port for this hypothesis from models stratified by urbanisation, which showed weak evidence
of the effect of intervention in the least urbanised villages (S3 Table). However, future fol-
low-ups of the participants will be able to provide much greater clarity as the cardiovascular
phenotypes mature with age.
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Implications
Cardiovascular disease is the leading cause of death and disability in LMICs [1]. The Develop-
mental Origins of Health and Disease hypothesis is of great importance to the unfolding epi-
demic of cardiovascular disease in many LMICs undergoing nutrition transition, notably
countries of South Asia (home to a quarter of the world’s population), where up to a quarter of
all births are low birth weight [25,26]. These data could not confirm a clear benefit of balanced
protein-calorie food supplementation given to undernourished pregnant women and children
on cardiovascular disease prevention. Conversely, there was no increase in cardiovascular risk
associated with nutritional supplementation, which is important for similar food supplementa-
tion programmes in many LMICs that are now concerned about the emerging epidemics of
obesity and cardiovascular disease [27]. Given the study limitations and young age of the par-
ticipants, adverse cardiovascular effects of undernutrition in pregnancy and childhood cannot
be ruled out; however, data from trial evidence to date do not support the ‘real-world’ effec-
tiveness of balanced protein-calorie interventions in pregnancy and/or childhood. There are
other potential benefits of improved child nutrition, including respiratory function, cognition,
schooling and labour market participation, and reproductive health, which have also been
noted in APCAPs [20]. However, until further evidence is available, policy makers should
attach limited value to cardiovascular health benefits of maternal and child protein-calorie
food supplementation programmes. Meanwhile, further research involving long-term follow-
up of participants of intervention studies in which the compliance is monitored is needed to
provide more conclusive evidence.
Conclusions
In an area with prevalent undernutrition, protein-calorie food supplementation offered to
pregnant women and their offspring in childhood did not lower the offspring’s risk of
Fig 3. Comparison of findings for selected outcomes in APCAPs participants presenting at first follow-up (FU1,
mean age 16 years) and second or third follow-up (FU2/3, mean age 22 years). Data shown are means and 95%
confidence intervals (blue bars, control; red bars, intervention). �Geometric mean was used for this variable. APCAPs,
Andhra Pradesh Children and Parents study; BP, blood pressure.
https://doi.org/10.1371/journal.pmed.1003183.g003
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cardiovascular disease in young adulthood. While adverse cardiovascular effects of undernu-
trition in pregnancy and childhood cannot be ruled out, data from intervention studies to date
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